Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 42.30
+0.70 (1.68%)
Sep 4, 2026, 4:44 PM CET
Urteste Market Cap
Urteste has a market cap or net worth of 64.55 million as of September 4, 2026. Its market cap has decreased by -10.21% in one year.
Market Cap
64.55M
Enterprise Value
61.57M
Revenue
2.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.30
ChartMarket Cap Chart
Since October 27, 2021, Urteste's market cap has decreased from 110.64M to 64.55M, a decrease of -41.65%. That is a compound annual growth rate of -10.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 64.55M | 17.42% |
| Dec 30, 2025 | 54.98M | -59.03% |
| Dec 30, 2024 | 134.20M | -12.66% |
| Dec 29, 2023 | 153.65M | 70.57% |
| Dec 30, 2022 | 90.08M | -17.62% |
| Dec 30, 2021 | 109.35M | -1.16% |
| Oct 27, 2021 | 110.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 497.56M |
| Captor Therapeutics Spolka Akcyjna | 451.09M |
| Bioceltix | 439.26M |
| Ryvu Therapeutics | 401.37M |
| BIOTON | 323.71M |
| Synthaverse | 226.55M |
| Poltreg | 136.67M |
| Molecure | 131.86M |